Labeling
The label states:
FATAL IF GIVEN INTRATHECALLY.
FOR INTRAVENOUS USE ONLY. Where labeled as containing more than 2 mg, it must also be labeled as a
Pharmacy Bulk Package (see
Injections 1). The labeling directs that the drug be dispensed only in containers enclosed in an overwrap labeled as directed below. When packaged in a
Pharmacy Bulk Package, it is exempt from the requirement under
Injections 1, that the closure be penetrated only one time after constitution with a suitable sterile transfer device or dispensing set, when it contains a suitable substance or mixture of substances to prevent the growth of microorganisms.
When dispensed, the container or syringe (holding the individual dose prepared for administration to the patient) must be enclosed in an overwrap bearing the statement DO NOT REMOVE COVERING UNTIL MOMENT OF INJECTION. FATAL IF GIVEN INTRATHECALLY. FOR INTRAVENOUS USE ONLY.
Identification
Spray reagent
Dissolve 2.0 g of ceric ammonium sulfate in 100 mL of water with heating and stirring, and slowly add 100 mL of phosphoric acid. Filter if necessary.
Procedure
Dissolve a sufficient quantity in water to obtain a solution containing 25 mg per mL. Further dilute the solution to 10 mg per mL with methanol, and mix. Also prepare a 10-mg-per-mL solution of
USP Vincristine Sulfate RS in a mixture of dichloromethane and methanol (3:1), and mix. Use a thin-layer chromatographic plate coated with a 0.25-mm layer of chromatographic silica gel mixture (see
Chromatography 621). Develop it in a methanol prewash tank, and dry it, for maximum sensitivity, not more than 2 hours before use. Score it about 15 cm above the points of application. Apply 20 µL of each solution at points about 2.5 cm from the lower edge of the plate, and dry thoroughly (a current of cool air may be used to help dry the spots). Prepare the developing solvent system consisting of a mixture of fresh ether, methanol, and methylamine solution (2 in 5) (95:10:5) immediately prior to development. Place the plate in the nonequilibrated developing chamber that contains a paper liner around the back and sides and developing solvent to a depth of about 2 cm. Remove the plate when the solvent moves to the scored line (about 80 minutes), and discard the solvent system. Dry the plate in a fume hood at room temperature, heat on a metal plate on a steam bath for about 15 minutes, and spray the plate while still hot with
Spray reagent. Continue heating the plate for 15 minutes to stabilize the spots: the
RF value and the color of the principal spot obtained from the test specimen correspond to those obtained from the Reference Standard.
Uniformity of dosage units 905
It meets the requirements for solids.
Procedure for content uniformity
Buffer solution
Dissolve 6.3 g of ammonium formate in about 900 mL of water in a 1000-mL volumetric flask, adjust with formic acid to a pH of 5.0 while stirring, dilute with water to volume, and mix.
Standard preparation
Dissolve an accurately weighed quantity of
USP Vincristine Sulfate RS in
Buffer solution, and dilute quantitatively and stepwise with
Buffer solution to obtain a solution having a known concentration of about 40 µg per mL.
Test preparation
Dissolve the contents of 1 container of Vincristine Sulfate for Injection in an accurately measured volume of Buffer solution to obtain a solution having a concentration between 40 and 50 µg per mL.
Procedure
Concomitantly determine the absorbances of the
Test preparation and the
Standard preparation in 1-cm cells at the wavelength of maximum absorbance at about 262 nm versus the
Buffer solution as the blank. Calculate the quantity, in mg, of C
46H
56N
4O
10·H
2SO
4 in the container taken by the formula:
0.001CV(AU / AS),
in which
C is the concentration, in µg per mL, of
USP Vincristine Sulfate RS (corrected for loss in weight) in the
Standard preparation, V is the volume, in mL, to which the contents of the container are diluted, and
AU and
AS are the absorbances of the
Test preparation and the
Standard preparation, respectively.
Related compounds
Proceed as directed in the test for
Related compounds under
Vincristine Sulfate. The total of the responses due to related substances does not exceed 5.0%, and no single related substance response exceeds 2.0%.
Assay
Mobile phase, Standard preparation, System suitability preparation, and Chromatographic system
Prepare as directed in the
Assay under
Vincristine Sulfate.
Assay preparation
Pipet a suitable volume of water into a container of Vincristine Sulfate for Injection to obtain a solution having a concentration of about 1 mg of vincristine sulfate per mL. Insert the stopper, and shake to mix.
Procedure
Proceed as directed for
Procedure in the
Assay under
Vincristine Sulfate. Calculate the quantity, in mg, of vincristine sulfate (C
46H
56N
4O
10·H
2SO
4) in the portion of Vincristine Sulfate for Injection taken by the formula:
10C(rU / rS),
in which
C is the concentration, in mg per mL, of
USP Vincristine Sulfate RS corrected for loss in weight in the
Standard preparation; and
rU and
rS are the peak responses for vincristine sulfate obtained from the
Assay preparation and the
Standard preparation, respectively.